Description
TRUST CAL-CARE TAB is a versatile film-coated oral tablet designed to support calcium supplementation and provide relief from heartburn. Each tablet contains 600 mg of calcium, formulated as calcium carbonate, offering a reliable source of this essential mineral.
Key Features
- Formulation: The tablets are large but can be conveniently broken in half, allowing for flexible dosing.
- Packaging: Each bottle contains 120 tablets, providing a substantial supply for ongoing use.
Usage Instructions
- Administration: For optimal results, swallow the tablets with a full glass of water.
- Guidance: Adhere to the directions provided by a healthcare professional and always read the label carefully.
- Consultation: It's advisable to seek medical advice before use, particularly if symptoms persist.
Dosage Information
- Supplementation: Typical adult dosage ranges from 500 mg to 4 g daily, divided across meals.
- Heartburn Relief: Recommended dosing is between 500 mg to 1000 mg per dose, not exceeding 7 g daily.
Safety Considerations
TRUST CAL-CARE TAB is generally considered safe during pregnancy and breastfeeding when used as directed. Potential side effects include high calcium levels, low phosphate levels, nausea, constipation, gas, and loss of appetite. Long-term excessive use may lead to more serious conditions such as hypercalcemia and kidney-related issues.
Contraindications
- Hypersensitivity
- Renal calculus
- Hypercalcemia
- Hypophosphatemia
- Achlorhydria
- Suspected digoxin toxicity
Drug Interactions
Calcium absorption may be affected by interactions with certain medications, including bisphosphonates, fluoroquinolones, tetracyclines, thyroid hormones, and others. Monitoring of serum calcium and phosphate is recommended, especially for patients with kidney disease or those on long-term use.
Storage Instructions
Store the tablets at room temperature, away from heat and freezing conditions, to maintain their efficacy.
Regulatory Information
TRUST CAL-CARE TAB is listed on the Australian Register of Therapeutic Goods (ARTG) and verified on the Repatriation Schedule of Pharmaceutical Benefits (RPBS) as of June 1, 2025, ensuring compliance with relevant healthcare standards.
